{"id":"https://openalex.org/W7221584926","doi":"https://doi.org/10.3389/fphar.2026.1924891","title":"Adipose-derived mesenchymal stem cell-derived exosomal miR-22-3p alleviates depression-like behaviors in a rat model via the FURIN/HMGB1 axis","display_name":"Adipose-derived mesenchymal stem cell-derived exosomal miR-22-3p alleviates depression-like behaviors in a rat model via the FURIN/HMGB1 axis","publication_year":2026,"publication_date":"2026-10-13","ids":{"openalex":"https://openalex.org/W7221584926","doi":"https://doi.org/10.3389/fphar.2026.1924891","pmid":"https://pubmed.ncbi.nlm.nih.gov/42947966","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13710244"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1924891","doi":"https://doi.org/10.3389/fphar.2026.1924891","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1924891","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1924891/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1924891/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040549290","display_name":"Yuxin Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113348","display_name":"Guangxi University of Chinese Medicine","ror":"https://ror.org/024v0gx67","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113348"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuxin Xu","raw_affiliation_strings":["Guangxi University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangxi University of Chinese Medicine","institution_ids":["https://openalex.org/I4210113348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085590993","display_name":"\u6e38\u8273\u79cb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113348","display_name":"Guangxi University of Chinese Medicine","ror":"https://ror.org/024v0gx67","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113348"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yanqiu You","raw_affiliation_strings":["The Second Affiliated Hospital of Guangxi University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Affiliated Hospital of Guangxi University of Chinese Medicine","institution_ids":["https://openalex.org/I4210113348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140723179","display_name":"Dekai Wei","orcid":"https://orcid.org/0009-0004-0370-1723","observed_orcids":["https://orcid.org/0009-0004-0370-1723"]},"institutions":[{"id":"https://openalex.org/I4210113348","display_name":"Guangxi University of Chinese Medicine","ror":"https://ror.org/024v0gx67","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113348"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dekai Wei","raw_affiliation_strings":["Guangxi University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangxi University of Chinese Medicine","institution_ids":["https://openalex.org/I4210113348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158571750","display_name":"Rong Liang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113348","display_name":"Guangxi University of Chinese Medicine","ror":"https://ror.org/024v0gx67","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113348"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Rong Liang","raw_affiliation_strings":["Guangxi University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guangxi University of Chinese Medicine","institution_ids":["https://openalex.org/I4210113348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158612704","display_name":"Weiping Liang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113348","display_name":"Guangxi University of Chinese Medicine","ror":"https://ror.org/024v0gx67","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113348"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Weiping Liang","raw_affiliation_strings":["The Second Affiliated Hospital of Guangxi University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Affiliated Hospital of Guangxi University of Chinese Medicine","institution_ids":["https://openalex.org/I4210113348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158660604","display_name":"Bingzheng Feng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113348","display_name":"Guangxi University of Chinese Medicine","ror":"https://ror.org/024v0gx67","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113348"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bingzheng Feng","raw_affiliation_strings":["The Second Affiliated Hospital of Guangxi University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Affiliated Hospital of Guangxi University of Chinese Medicine","institution_ids":["https://openalex.org/I4210113348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158574291","display_name":"Jibing Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113348","display_name":"Guangxi University of Chinese Medicine","ror":"https://ror.org/024v0gx67","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210113348"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jibing Chen","raw_affiliation_strings":["The Second Affiliated Hospital of Guangxi University of Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Affiliated Hospital of Guangxi University of Chinese Medicine","institution_ids":["https://openalex.org/I4210113348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100530946","display_name":"Jia Liang","orcid":"https://orcid.org/0000-0002-4111-6080","observed_orcids":["https://orcid.org/0000-0002-4111-6080"]},"institutions":[{"id":"https://openalex.org/I4210115919","display_name":"The People's Hospital of Guangxi Zhuang Autonomous Region","ror":"https://ror.org/02aa8kj12","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210115919"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jia Liang","raw_affiliation_strings":["The People's Hospital of Guangxi Zhuang Autonomous Region"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The People's Hospital of Guangxi Zhuang Autonomous Region","institution_ids":["https://openalex.org/I4210115919"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5140590432","display_name":"Fujun Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I176834541","display_name":"Guangdong Medical College","ror":"https://ror.org/04k5rxe29","country_code":"CN","type":"education","lineage":["https://openalex.org/I176834541"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fujun Li","raw_affiliation_strings":["The Second Affiliated Hospital of Guangdong Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Affiliated Hospital of Guangdong Medical University","institution_ids":["https://openalex.org/I176834541"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.65008311,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1924891","last_page":"1924891"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10773","display_name":"Extracellular vesicles in disease","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10773","display_name":"Extracellular vesicles in disease","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.01209999993443489,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9660000205039978},{"id":"https://openalex.org/keywords/engineered-exosomes","display_name":"engineered exosomes","score":0.7580000162124634},{"id":"https://openalex.org/keywords/adipose-derived-stem-cells","display_name":"adipose-derived stem cells","score":0.9200000166893005},{"id":"https://openalex.org/keywords/mir-22-3p","display_name":"miR-22-3p","score":0.984000027179718},{"id":"https://openalex.org/keywords/furin","display_name":"furin","score":0.859000027179718},{"id":"https://openalex.org/keywords/hmgb1","display_name":"HMGB1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.8999999761581421},{"id":"https://openalex.org/keywords/neuronal-apoptosis","display_name":"neuronal apoptosis","score":0.9549999833106995},{"id":"https://openalex.org/keywords/chronic-unpredictable-mild-stress","display_name":"chronic unpredictable mild stress","score":0.8529999852180481},{"id":"https://openalex.org/keywords/intranasal-drug-delivery","display_name":"intranasal drug delivery","score":0.8159999847412109},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.8029999732971191},{"id":"https://openalex.org/keywords/microrna-delivery","display_name":"microRNA delivery","score":0.8080000281333923},{"id":"https://openalex.org/keywords/hippocampus","display_name":"hippocampus","score":0.7129999995231628},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.9229999780654907}],"concepts":[{"id":"https://openalex.org/C20518536","wikidata":"https://www.wikidata.org/wiki/Q6840469","display_name":"Microvesicles","level":4,"score":0.8147000074386597},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.7634000182151794},{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.6495000123977661},{"id":"https://openalex.org/C198826908","wikidata":"https://www.wikidata.org/wiki/Q1922379","display_name":"Mesenchymal stem cell","level":2,"score":0.6449999809265137},{"id":"https://openalex.org/C2781261824","wikidata":"https://www.wikidata.org/wiki/Q903634","display_name":"Exosome","level":5,"score":0.5831999778747559},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.5346999764442444},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.501800000667572},{"id":"https://openalex.org/C3019114686","wikidata":"https://www.wikidata.org/wiki/Q3089676","display_name":"Rat model","level":2,"score":0.4853000044822693},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4839000105857849},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47450000047683716},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4555000066757202},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.3871999979019165},{"id":"https://openalex.org/C2780545709","wikidata":"https://www.wikidata.org/wiki/Q21130552","display_name":"HMGB1","level":3,"score":0.3644999861717224},{"id":"https://openalex.org/C25938499","wikidata":"https://www.wikidata.org/wiki/Q7663812","display_name":"Systemic administration","level":3,"score":0.3634999990463257},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34470000863075256},{"id":"https://openalex.org/C148762608","wikidata":"https://www.wikidata.org/wiki/Q3748185","display_name":"Hippocampal formation","level":2,"score":0.32600000500679016},{"id":"https://openalex.org/C196795494","wikidata":"https://www.wikidata.org/wiki/Q1624817","display_name":"TUNEL assay","level":3,"score":0.31839999556541443},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.3116999864578247},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2865999937057495},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2858000099658966},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.28029999136924744},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.2741999924182892},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2720000147819519},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.258899986743927}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fphar.2026.1924891","doi":"https://doi.org/10.3389/fphar.2026.1924891","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1924891","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1924891/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-10130523/v1","doi":"https://doi.org/10.21203/rs.3.rs-10130523/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-10130523/v1","pdf_url":"https://www.researchsquare.com/article/rs-10130523/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:13710244","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13710244/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13710244/pdf/fphar-17-1924891.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:42947966","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42947966","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:06407f37a32d472ebd56ead1603b97b3","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/06407f37a32d472ebd56ead1603b97b3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1924891","doi":"https://doi.org/10.3389/fphar.2026.1924891","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1924891","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1924891/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2210368206","display_name":null,"funder_award_id":"AB24010083","funder_id":"https://openalex.org/F4320336589","funder_display_name":"Guangxi Key Research and Development Program"},{"id":"https://openalex.org/G600702592","display_name":null,"funder_award_id":"AB25069271","funder_id":"https://openalex.org/F4320336589","funder_display_name":"Guangxi Key Research and Development Program"},{"id":"https://openalex.org/G8590596640","display_name":null,"funder_award_id":"2025GXNSFAA0691007","funder_id":"https://openalex.org/F4320336589","funder_display_name":"Guangxi Key Research and Development Program"}],"funders":[{"id":"https://openalex.org/F4320322768","display_name":"Natural Science Foundation of Guangxi Province","ror":null},{"id":"https://openalex.org/F4320336589","display_name":"Guangxi Key Research and Development Program","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7221584926.pdf","grobid_xml":"https://content.openalex.org/works/W7221584926.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W1500090786","https://openalex.org/W1964681233","https://openalex.org/W1977832796","https://openalex.org/W2026643924","https://openalex.org/W2045414564","https://openalex.org/W2067236528","https://openalex.org/W2069437848","https://openalex.org/W2079013802","https://openalex.org/W2089198034","https://openalex.org/W2126623223","https://openalex.org/W2136153483","https://openalex.org/W2137097534","https://openalex.org/W2156118453","https://openalex.org/W2166817991","https://openalex.org/W2790852710","https://openalex.org/W2917495712","https://openalex.org/W2944971749","https://openalex.org/W2983336586","https://openalex.org/W3026879754","https://openalex.org/W3121879279","https://openalex.org/W3143881404","https://openalex.org/W3170462235","https://openalex.org/W3193861087","https://openalex.org/W3209302925","https://openalex.org/W4285092878","https://openalex.org/W4289261780","https://openalex.org/W4292297610","https://openalex.org/W4294668421","https://openalex.org/W4294911967","https://openalex.org/W4297973312","https://openalex.org/W4312066812","https://openalex.org/W4367315218","https://openalex.org/W4377246850","https://openalex.org/W4388682038","https://openalex.org/W4391954755","https://openalex.org/W4392593596","https://openalex.org/W4407830622"],"related_works":["https://openalex.org/W7168270882","https://openalex.org/W4409501548","https://openalex.org/W6958616722","https://openalex.org/W4411396199","https://openalex.org/W3008332201","https://openalex.org/W7157067054","https://openalex.org/W4403613433","https://openalex.org/W3003054559","https://openalex.org/W4409188201","https://openalex.org/W4221075588"],"abstract_inverted_index":{"Background:":[0],"Major":[1],"depressive":[2],"disorder":[3],"(MDD)":[4],"is":[5],"characterized":[6],"by":[7,37,171],"neuroinflammation":[8],"and":[9,83,91,103,118,134,143,176],"neuronal":[10,146],"apoptosis,":[11],"yet":[12],"effective":[13],"brain-targeted":[14],"delivery":[15,187],"strategies":[16],"remain":[17],"limited.":[18],"Exosomes":[19],"represent":[20],"promising":[21],"carriers":[22],"capable":[23],"of":[24,55,111,162],"crossing":[25],"the":[26,39,173],"blood-brain":[27],"barrier.":[28],"This":[29,179],"study":[30,180],"investigated":[31],"whether":[32],"engineered":[33,112],"exosomes":[34,70,113,167],"delivering":[35],"miR-22-3p":[36,95,116],"modulating":[38],"FURIN/HMGB1":[40],"axis.":[41],"Methods:":[42],"Serum":[43],"microRNA":[44,186],"expression":[45],"was":[46,57,96],"assessed":[47],"in":[48,99],"patients":[49,102],"with":[50],"MDD.":[51,190],"A":[52],"rat":[53],"model":[54],"depression":[56],"established":[58],"using":[59],"chronic":[60],"unpredictable":[61],"mild":[62],"stress":[63],"(CUMS).":[64],"miR-22-3p-engineered":[65,166],"adipose-derived":[66],"mesenchymal":[67],"stem":[68],"cell":[69],"were":[71,86,157],"administered":[72],"intranasally.":[73],"Behavioral":[74],"tests":[75],"(SPT,":[76],"OFT,":[77],"FST),":[78],"RT-qPCR,":[79],"ELISA,":[80],"HE":[81],"staining,":[82],"TUNEL":[84],"assays":[85],"performed":[87],"to":[88],"evaluate":[89],"neurobehavioral":[90],"molecular":[92],"changes.":[93],"Results:":[94],"significantly":[97,119],"downregulated":[98],"both":[100],"MDD":[101],"CUMS":[104],"rats":[105],"(P":[106,123,148],"<":[107,124,128,149,153],"0.01).":[108,129,154],"Intranasal":[109],"administration":[110],"increased":[114],"brain":[115],"levels":[117],"improved":[120],"depressive-like":[121],"behaviors":[122],"0.05":[125,150],"or":[126,151],"P":[127,152],"Mechanistically,":[130],"treatment":[131],"suppressed":[132],"FURIN":[133],"HMGB1":[135],"expression,":[136],"reduced":[137],"proinflammatory":[138],"cytokines":[139],"(IL-1\u03b2,":[140],"IL-6,":[141],"TNF-\u03b1),":[142],"attenuated":[144],"hippocampal":[145],"apoptosis":[147],"These":[155],"effects":[156,170],"more":[158],"pronounced":[159],"than":[160],"those":[161],"native":[163],"exosomes.":[164],"Conclusions:":[165],"exert":[168],"antidepressant":[169],"inhibiting":[172],"FURIN/HMGB1-mediated":[174],"neuroinflammatory":[175],"apoptotic":[177],"pathways.":[178],"highlights":[181],"a":[182],"novel":[183],"intranasal":[184],"exosome-based":[185],"strategy":[188],"for":[189]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-14T00:00:00"}